Current State and Local Tax Expense (Benefit) of Emmaus Life Sciences, Inc. from 30 Sep 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Emmaus Life Sciences, Inc. quarterly and annual Current State and Local Tax Expense (Benefit) in USD history and change rate from 30 Sep 2017 to 30 Sep 2025.
  • Emmaus Life Sciences, Inc. Current State and Local Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $579,000.
  • Emmaus Life Sciences, Inc. Current State and Local Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $23,000, a 81% increase year-over-year.
  • Emmaus Life Sciences, Inc. annual Current State and Local Tax Expense (Benefit) for 2024 was $7,000.
  • Emmaus Life Sciences, Inc. annual Current State and Local Tax Expense (Benefit) for 2023 was $94,000, a 413% decline from 2022.
  • Emmaus Life Sciences, Inc. annual Current State and Local Tax Expense (Benefit) for 2022 was $30,000.
Source SEC data
View on sec.gov
Current State and Local Tax Expense (Benefit), Trailing 12 Months (USD)
Current State and Local Tax Expense (Benefit), Quarterly (USD)
Current State and Local Tax Expense (Benefit), YoY Quarterly Change (%)
Current State and Local Tax Expense (Benefit), Annual (USD)
Current State and Local Tax Expense (Benefit), YoY Annual Change (%)

Emmaus Life Sciences, Inc. Quarterly Current State and Local Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $23,000 $579,000 +$580,000 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $603,000 $590,000 -$621,000 -2003% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $18,000 $4,000 +$11,000 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $7,000 $16,000 +$131,000 +89% 01 Oct 2024 31 Dec 2024 10-K 14 Apr 2025 2024 FY
Q3 2024 $124,000 $1,000 -$39,000 -103% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $85,000 $31,000 +$65,000 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $150,000 $7,000 -$56,000 -114% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $94,000 $147,000 01 Oct 2023 31 Dec 2023 10-K 14 Apr 2025 2024 FY
Q3 2023 $38,000 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024 2024 Q3
Q2 2023 $34,000 01 Apr 2023 30 Jun 2023 10-Q 10 Sep 2024 2024 Q2
Q1 2023 $49,000 01 Jan 2023 31 Mar 2023 10-Q 10 Sep 2024 2024 Q1

Emmaus Life Sciences, Inc. Annual Current State and Local Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $7,000 +$101,000 01 Jan 2024 31 Dec 2024 10-K 14 Apr 2025 2024 FY
2023 $94,000 -$124,000 -413% 01 Jan 2023 31 Dec 2023 10-K 14 Apr 2025 2024 FY
2022 $30,000 01 Jan 2022 31 Dec 2022 10-K 03 Jul 2024 2023 FY
2018 $1,900 -$700 -27% 01 Oct 2017 30 Sep 2018 10-K 11 Dec 2018 2018 FY
2017 $2,600 01 Oct 2016 30 Sep 2017 10-K 11 Dec 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.